Cleared Traditional

K771947 - INSULIN RIA MODULE

K771947 is the FDA 510(k) clearance for INSULIN RIA MODULE by Inter Science Institute. It is a Class 1 Immunology device (product code CFP) cleared through the Traditional 510(k) pathway after a 95-day FDA review.

K771947 · Inter Science Institute · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1978
Decision
95d
Days
Class 1
Risk

K771947 is an FDA 510(k) clearance for the INSULIN RIA MODULE. Classified as Radioimmunoassay, Immunoreactive Insulin (product code CFP), Class I - General Controls.

Submitted by Inter Science Institute (Mchenry, US). The FDA issued a Cleared decision on January 20, 1978 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1405 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Inter Science Institute devices

Submission Details

510(k) Number K771947 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 17, 1977
Decision Date January 20, 1978
Days to Decision 95 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 104d · This submission: 95d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CFP Radioimmunoassay, Immunoreactive Insulin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1405
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CFP Radioimmunoassay, Immunoreactive Insulin

All 17
Devices cleared under the same product code (CFP) and FDA review panel - the closest regulatory comparables to K771947.
AUTOPAK 12 INSULIN TEST DELIVERY SYSTEM
K792279 · Micromedic Systems · Dec 1979
CENTRIA INSULIN RIA
K791707 · Ventrex Laboratories, Inc. · Oct 1979
INSULIN AUTOPAK
K781086 · Micromedic Systems · Aug 1978
CENTRIA INSULIN RIA
K771979 · Union Carbide Corp. · Nov 1977
NSULIN RIA KIT 125I
K771628 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1977